$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
028-123456789
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
medicaldrugs
medicaldrugs
What are the common side effects of F/TAF? How to deal with and alleviate side effects
2026-02-01 22:25:32
Check Details
Whether Febuxostat (Febuxostat) can be taken for a long time and analysis of its safety during long-term use
2026-02-01 22:25:32
Check Details
Detailed description of dosage, usage and adjustment suggestions during taking furmonertinib
2026-02-01 22:25:32
Check Details
Analysis of how long a box of ensifentrine-Ohtuvayre can be used and the dosage of the treatment course
2026-02-01 22:25:32
Check Details
Management and monitoring plan for patients with abnormal liver function on Pimitespib
2026-02-01 22:25:32
Check Details
Is afatinib (Gitairin) a first- or second-generation targeted drug and its characteristics?
2026-02-01 22:25:32
Check Details
Comprehensive comparison of the efficacy and safety of DaliRasheng (Keweike) and traditional sleeping pills
2026-02-01 22:25:32
Check Details
Analysis of whether olaparib (lipadro) can be used in the treatment of lymphoma
2026-02-01 22:25:32
Check Details
Comparative analysis of venetoclax/venetoclax (venetoclax) alternative drugs and similar drugs
2026-02-01 22:25:32
Check Details
Instructions on the long-term medication safety and precautions of Asnib/Asiminib (Sinbel)
2026-02-01 22:25:32
Check Details
How long does it take to cure alopecia areata and the recommended course of treatment with ritexitinib?
2026-02-01 22:25:32
Check Details
Sparsentan (sparsentan) dosage, usage and medication instructions
2026-02-01 22:25:32
Check Details
1
2
...
2192
2193
2194
2195
2196
2197
2198
...
2438
2439
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
User Agreement
2
Herceptin Hylecta treats HER2-positive breast cancer and only needs to be injected subcutaneously and only used once every three weeks
3
What is the most important information I should know about WELIREG?
4
How to take and store WELIREG
5
How to take TRUSELTIQ correctly
6
How to deal with LONSURF side effects (1)
7
How to deal with LONSURF side effects (2)
8
Cabozantinib (Cabometyx)-new indication approved
9
What should I pay attention to when using atezolizumab/Tecentriq?
10
Darzalex Faspro, Kyprolis and dexamethasone "three swords combined" to treat multiple myeloma
11
Rituximab combined with chemotherapy approved in the United States for pediatric patients with specific malignant tumors
12
Lenvatinib and pembrolizumab trial results in unresectable hepatocellular carcinoma